journal article·2019-10-16

Effect of PEGylated Magnetic PLGA-PEI Nanoparticles on Primary Hippocampal Neurons: Reduced Nanoneurotoxicity and Enhanced Transfection Efficiency with Magnetofection

Yanna Cui, Xiao Li, Kristina Zeljic, Shifang Shan, Zilong Qiu, Zheng Wang

ACS Applied Materials & Interfaces· Volume 11· Issue 41
Publisher page

Abstract

Despite broad application of nanotechnology in neuroscience, the nanoneurotoxicity of magnetic nanoparticles in primary hippocampal neurons remains poorly characterized. In particular, understanding how magnetic nanoparticles perturb neuronal calcium homeostasis is critical when considering magnetic nanoparticles as a nonviral vector for effective gene therapy in neuronal diseases. Here, we address the pressing need to systematically investigate the neurotoxicity of magnetic nanoparticles with different surface charges in primary hippocampal neurons. We found that unlike negative and neutral nanoparticles, positively charged magnetic nanoparticles (magnetic poly(lactic-co-glycolic acid) (PLGA)-polyethylenimine (PEI) nanoparticles, MNP-PLGA-PEI NPs) rapidly elevated cytoplasmic calcium levels in primary hippocampal neurons, mainly via extracellular calcium influx regulated by voltage-gated calcium channels. We went on to show that this perturbation of intracellular calcium homeostasis elicited serious cytotoxicity in primary hippocampal neurons. However, our next experiment demonstrated that PEGylation on the surface of MNP-PLGA-PEI NPs shielded the surface charge, thereby preventing the perturbation of intracellular calcium homeostasis. That is, PEGylated MNP-PLGA-PEI NPs reduced nanoneurotoxicity. Importantly, biocompatible PEGylated MNP-PLGA-PEI NPs under an external magnetic field enhanced transfection efficiency (>7%) of plasmid DNA encoding GFP in primary hippocampal neurons compared to NPs without external magnetic field mediation. Moreover, under an external magnetic field, this system achieved gene transfection in the hippocampus of the C57 mouse. Overall, this study is the first to successfully employ biocompatible PEGylated MNP-PLGA-PEI NPs for transfection using a magnetofection strategy in primary hippocampal neurons, thereby providing a nanoplatform as a new perspective for treating neuronal diseases or modulating neuron activities.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticles: synthesis and applications · Molecular Communication and Nanonetworks

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, State Key Laboratory of Neuroscience, CAS Key Laboratory of Primate Neurobiology, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China

School of Basic Medical Science, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China

University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China

Kunming Institute of Zoology, Chinese Academy of Sciences, 32 Jiaochang East Road, Kunming, Yunnan 650223, China

Shanghai Research Center for Brain Science and Brain-inspired Intelligence Technology, 100 Haike Road, Shanghai 201210, China

Funding

Natural Science Foundation of Shanghai · Ministry of Science and Technology of the People's Republic of China · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China · Chinese Academy of Sciences

References (60)

Show source-provided references
1. 10.1038/s41593-019-0352-010.1038/s41593-019-0352-0 ↗
2. 10.1016/j.neuron.2019.03.01410.1016/j.neuron.2019.03.014 ↗
3. 10.1016/j.wneu.2018.09.09710.1016/j.wneu.2018.09.097 ↗
4. 10.1166/jbn.2018.260410.1166/jbn.2018.2604 ↗
5. 10.1016/j.biomaterials.2015.04.05210.1016/j.biomaterials.2015.04.052 ↗
6. 10.1002/anie.20140980310.1002/anie.201409803 ↗
7. 10.1016/bs.pbr.2019.03.00410.1016/bs.pbr.2019.03.004 ↗
8. 10.2147/IJN.S16567510.2147/IJN.S165675 ↗
9. 10.1021/acsami.6b1017510.1021/acsami.6b10175 ↗
10. 10.1002/jcp.2598010.1002/jcp.25980 ↗
11. 10.1016/j.bmcl.2017.08.03710.1016/j.bmcl.2017.08.037 ↗
12. 10.7150/thno.3030210.7150/thno.30302 ↗
13. 10.1016/j.biomaterials.2017.08.03610.1016/j.biomaterials.2017.08.036 ↗
14. 10.1002/mabi.20120025510.1002/mabi.201200255 ↗
15. 10.1080/20022727.2018.148849710.1080/20022727.2018.1488497 ↗
16. 10.1073/pnas.071171410510.1073/pnas.0711714105 ↗
17. 10.1007/s13346-012-0124-910.1007/s13346-012-0124-9 ↗
18. 10.1016/j.jconrel.2007.03.01210.1016/j.jconrel.2007.03.012 ↗
19. 10.1021/acs.nanolett.6b0253610.1021/acs.nanolett.6b02536 ↗
20. 10.1021/acs.biomac.7b0008010.1021/acs.biomac.7b00080 ↗
21. 10.1016/S0143-4160(03)00141-610.1016/S0143-4160(03)00141-6 ↗
22. 10.1016/j.ceca.2016.02.01110.1016/j.ceca.2016.02.011 ↗
23. 10.1097/ALN.000000000000173010.1097/ALN.0000000000001730 ↗
24. 10.1002/smll.20100228710.1002/smll.201002287 ↗
25. 10.1016/bs.pbr.2019.03.00510.1016/bs.pbr.2019.03.005 ↗
26. 10.1016/j.biocel.2015.07.01210.1016/j.biocel.2015.07.012 ↗
27. 10.1289/ehp.1122510.1289/ehp.11225 ↗
28. 10.1016/j.biocel.2013.06.00210.1016/j.biocel.2013.06.002 ↗
29. 10.1038/s41586-018-0716-810.1038/s41586-018-0716-8 ↗
30. 10.1038/s41467-019-08998-110.1038/s41467-019-08998-1 ↗
31. 10.1073/pnas.130417111010.1073/pnas.1304171110 ↗
32. 10.1007/s12640-013-9451-y10.1007/s12640-013-9451-y ↗
33. 10.1038/s41593-019-0352-010.1038/s41593-019-0352-0 ↗
34. 10.1021/acs.molpharmaceut.8b0132110.1021/acs.molpharmaceut.8b01321 ↗
35. 10.1021/acsami.8b1321610.1021/acsami.8b13216 ↗
36. 10.1080/1528739090348942210.1080/15287390903489422 ↗
37. 10.1093/toxsci/kfs00310.1093/toxsci/kfs003 ↗
38. 10.1016/j.ymthe.2005.02.01010.1016/j.ymthe.2005.02.010 ↗
39. 10.1016/j.actbio.2018.05.04010.1016/j.actbio.2018.05.040 ↗
40. 10.1021/jacs.7b0006510.1021/jacs.7b00065 ↗
41. 10.1016/j.biomaterials.2018.05.04310.1016/j.biomaterials.2018.05.043 ↗
42. 10.1021/nn202214910.1021/nn2022149 ↗
43. 10.1021/acsnano.5b0316210.1021/acsnano.5b03162 ↗
44. 10.1021/acs.nanolett.6b0420010.1021/acs.nanolett.6b04200 ↗
45. 10.1021/acsnano.5b0711810.1021/acsnano.5b07118 ↗
46. 10.1038/nrm115510.1038/nrm1155 ↗
47. 10.1523/JNEUROSCI.0675-06.200610.1523/JNEUROSCI.0675-06.2006 ↗
48. 10.1046/j.1471-4159.1996.67041735.x10.1046/j.1471-4159.1996.67041735.x ↗
49. 10.1073/pnas.050958810210.1073/pnas.0509588102 ↗
50. 10.1080/1528739090348942210.1080/15287390903489422 ↗
51. 10.3109/17435390.2015.101958510.3109/17435390.2015.1019585 ↗
52. 10.1002/smll.20160109410.1002/smll.201601094 ↗
53. 10.1016/j.mrrev.2017.05.00210.1016/j.mrrev.2017.05.002 ↗
54. 10.1002/jgm.301110.1002/jgm.3011 ↗
55. 10.1038/sj.gt.330131810.1038/sj.gt.3301318 ↗
56. 10.1038/nprot.2007.44510.1038/nprot.2007.445 ↗
57. 10.1242/dev.15138110.1242/dev.151381 ↗
58. 10.2116/analsci.31.29310.2116/analsci.31.293 ↗
59. 10.1523/JNEUROSCI.0183-10.201010.1523/JNEUROSCI.0183-10.2010 ↗
60. 10.1038/s41551-018-0318-710.1038/s41551-018-0318-7 ↗